SE423631B - PROCEDURE FOR THE PREPARATION OF OXALHYL DIALKYLXANTINES - Google Patents

PROCEDURE FOR THE PREPARATION OF OXALHYL DIALKYLXANTINES

Info

Publication number
SE423631B
SE423631B SE7407913A SE7407913A SE423631B SE 423631 B SE423631 B SE 423631B SE 7407913 A SE7407913 A SE 7407913A SE 7407913 A SE7407913 A SE 7407913A SE 423631 B SE423631 B SE 423631B
Authority
SE
Sweden
Prior art keywords
oxalhyl
dialkylxantines
procedure
preparation
oxalhyl dialkylxantines
Prior art date
Application number
SE7407913A
Other languages
Swedish (sv)
Other versions
SE7407913L (en
Inventor
W Mohler
M Jayme
J Komarek
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7407913L publication Critical patent/SE7407913L/xx
Publication of SE423631B publication Critical patent/SE423631B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7407913A 1973-06-16 1974-06-14 PROCEDURE FOR THE PREPARATION OF OXALHYL DIALKYLXANTINES SE423631B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2330742A DE2330742C2 (en) 1973-06-16 1973-06-16 1- (Oxoalkyl) -3-methyl-7-alkylxanthines, process for their preparation and pharmaceuticals containing them

Publications (2)

Publication Number Publication Date
SE7407913L SE7407913L (en) 1974-12-17
SE423631B true SE423631B (en) 1982-05-17

Family

ID=5884209

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7407913A SE423631B (en) 1973-06-16 1974-06-14 PROCEDURE FOR THE PREPARATION OF OXALHYL DIALKYLXANTINES

Country Status (17)

Country Link
US (1) US4289776A (en)
JP (1) JPS5233120B2 (en)
AR (3) AR208179A1 (en)
AT (1) AT334388B (en)
BE (1) BE816332A (en)
CH (2) CH608807A5 (en)
DE (1) DE2330742C2 (en)
DK (1) DK145676C (en)
ES (1) ES427171A1 (en)
FI (1) FI58920C (en)
FR (1) FR2233065B1 (en)
GB (1) GB1470220A (en)
IE (1) IE39898B1 (en)
NL (1) NL182806C (en)
NO (1) NO140300C (en)
SE (1) SE423631B (en)
ZA (1) ZA743760B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (en) 1974-01-22 1978-12-29 Wuelfing J A Fa
DE2507554A1 (en) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7- (OXOALKYL) -1,3-DIALKYLXANTHINE, METHOD OF PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE2507555A1 (en) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7- (OXOALKYL) -1,3-DIALKYLXANTHINE, THE METHOD OF MANUFACTURING THEREOF AND MEDICINAL PRODUCTS CONTAINING THIS COMPOUND
JPS54112893A (en) * 1978-02-21 1979-09-04 Kohjin Co Ltd Preparation of 1-(5'-oxohexyl)-3,7-diethylxanthine
EP0005015B1 (en) * 1978-04-22 1986-10-29 BEECHAM - WUELFING GmbH & Co. KG Use of a xanthine derivate in the manufacture of a medicament
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
EP0157098A1 (en) * 1980-06-21 1985-10-09 Beecham Wuelfing GmbH & Co KG Xanthine derivatives, pharmaceuticals compositions containing them and a process for their preparation
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
JPH062675B2 (en) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 Memory disorder treatment
GB8621869D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Treatment
JPS63225317A (en) * 1986-10-06 1988-09-20 Hoechst Japan Kk Antipeptic ulcer agent
IT1197516B (en) * 1986-12-24 1988-11-30 Abc Ist Biolog Chem Spa THEOFILLINMETYLANIC AND THEOFILLINMETYLDITIAN DERIVATIVES PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
DE3942872A1 (en) * 1989-12-23 1991-06-27 Hoechst Ag METHOD FOR THE ENANTIOSELECTIVE PRESENTATION OF ((OMEGA) -1) -HYDROXYALKYLXANTHINES
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
DE59207086D1 (en) * 1991-05-23 1996-10-17 Hoechst Ag The use of 1- (5-oxohexyl) -3-methyl-7-n-propyl-xanthine in vascular surgery
MX9203323A (en) * 1991-07-11 1994-07-29 Hoechst Ag THE USE OF XANTHINE DERIVATIVES FOR THE TREATMENT OF SECONDARY INJURIES OF THE NERVOUS CELLS AND FUNCTIONAL DISORDERS AFTER CRANIAL-BRAIN TRAUMA.
JP2549480B2 (en) * 1991-12-10 1996-10-30 ヘキストジャパン株式会社 Urinary disorder improving agent
EP0570831A2 (en) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Use of Xanthinderivatives for treatment of cerebral nerve dammages after disruption of the blood circulation
US6020337A (en) * 1993-04-05 2000-02-01 Cell Therapeutics, Inc. Electronegative-substituted long chain xanthine compounds
US5670506A (en) * 1993-04-05 1997-09-23 Cell Therapeutics, Inc. Halogen, isothiocyanate or azide substituted xanthines
WO1995020589A1 (en) * 1994-01-28 1995-08-03 Cell Therapeutics, Inc. Cell signaling inhibitors
US5762953A (en) * 1996-08-22 1998-06-09 Theratech, Inc. Transdermal propentofylline compositions for the treatment of Alzheimers disease
DE19707655A1 (en) * 1997-02-26 1998-08-27 Hoechst Ag Combination preparation for use in dementia
US20040110776A1 (en) * 2002-02-22 2004-06-10 Iok-Hou Pang Use of propentofylline to control intraocular pressure
EP2265334A2 (en) 2008-02-29 2010-12-29 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
IN2012DN01642A (en) 2009-09-02 2015-06-05 Concert Pharmaceuticals Inc
US11225481B2 (en) * 2015-12-29 2022-01-18 Centre National De La Recherche Scientifique Xanthine derivative inhibitors of BET proteins
CN112724160A (en) * 2021-03-19 2021-04-30 赤峰经方医药技术开发有限责任公司 Preparation method of pentoxifylline impurity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH325292A (en) * 1953-10-21 1957-10-31 Geigy Ag J R Process for the preparation of 7-oxyalkyl-xanthine derivatives
FR1211333A (en) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Improvements in processes for manufacturing oxyalkylxanthines
DE1233405B (en) 1964-09-05 1967-02-02 Albert Ag Chem Werke Process for the preparation of 7- (oxoalkyl) -1, 3-dimethylxanthines
US3422107A (en) 1964-09-05 1969-01-14 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines and a process for the preparation thereof
US3737433A (en) 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
DE1545689C2 (en) 1964-09-05 1982-07-01 Hoechst Ag, 6000 Frankfurt Process for the preparation of 2-methyl-3-carbethoxy-5,6-dihydropyran
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
DE1810705C3 (en) * 1968-11-25 1980-11-27 Hoechst Ag, 6000 Frankfurt Stabilization of vitamins
DE1911279A1 (en) * 1969-03-05 1970-11-12 Eckert Dr Theodor Process to increase the ability of drugs to be absorbed

Also Published As

Publication number Publication date
IE39898B1 (en) 1979-01-31
DK145676C (en) 1983-08-01
AR208179A1 (en) 1976-12-09
DK145676B (en) 1983-01-24
NO140300C (en) 1979-08-08
JPS5233120B2 (en) 1977-08-26
AT334388B (en) 1976-01-10
DE2330742C2 (en) 1982-07-29
NO140300B (en) 1979-04-30
NL7407890A (en) 1974-12-18
FI58920C (en) 1981-05-11
NL182806C (en) 1988-05-16
ATA491874A (en) 1976-05-15
GB1470220A (en) 1977-04-14
AR209320A1 (en) 1977-04-15
AU7014774A (en) 1975-12-18
DK321574A (en) 1975-02-10
AR209319A1 (en) 1977-04-15
DE2330742A1 (en) 1975-01-09
NL182806B (en) 1987-12-16
BE816332A (en) 1974-12-16
US4289776A (en) 1981-09-15
CH612969A5 (en) 1979-08-31
CH608807A5 (en) 1979-01-31
FR2233065B1 (en) 1978-07-21
FI58920B (en) 1981-01-30
JPS5047992A (en) 1975-04-28
FI181974A (en) 1974-12-17
SE7407913L (en) 1974-12-17
NO742121L (en) 1975-01-13
ES427171A1 (en) 1976-07-16
FR2233065A1 (en) 1975-01-10
ZA743760B (en) 1975-06-25
IE39898L (en) 1974-12-16

Similar Documents

Publication Publication Date Title
SE423631B (en) PROCEDURE FOR THE PREPARATION OF OXALHYL DIALKYLXANTINES
NO145273C (en) N-FORMYL-ALFA-L-ASPARTYL-L-PHENYLALANINE FOR USING THE PREPARATION OF ALFA-L-ASPARTYL-L-PHENYLALANINAL COOLESTERS
SE7710599L (en) PROCEDURE FOR THE PREPARATION OF BENSISOXAZOLES
NO142894C (en) PROCEDURE FOR THE PREPARATION OF POLYETHYLENTE REFATE
SE420604B (en) PROCEDURE FOR THE PREPARATION OF OXAZOLD DERIVATIVES
SE411212B (en) PROCEDURE FOR THE PREPARATION OF 3-HALOGEN-CEPHALOSPORINE
NO142628C (en) PROCEDURE FOR THE PREPARATION OF POLYLACTONES
RO70474A (en) PROCEDURE FOR THE PREPARATION OF PARAXILENUL
NO146596C (en) PROCEDURE FOR THE PREPARATION OF 6-DEOXYTE TRACYCLINES
SE7712151L (en) PROCEDURE FOR THE PREPARATION OF LINKOMYCIN DERIVATIVES
SE417721B (en) PROCEDURE FOR THE PREPARATION OF PHENOL-ALDEPHONE PLASTIC
SE417601B (en) PROCEDURE FOR THE PREPARATION OF AMIDINOCARBAMIDS
NO790627L (en) PROCEDURE FOR THE PREPARATION OF HYDROXYALKYLXANTINES
NO843825L (en) PROCEDURE FOR THE PREPARATION OF 6-DEOXYTHETRACYCLINE
TR17584A (en) PROCEDURE FOR THE PREPARATION OF HERBISID TRIASINS
NO140928C (en) PROCEDURE FOR THE PREPARATION OF XYLITOL
SE417319B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF ERGOPEPTIN
AR206610A1 (en) PROCEDURE FOR THE PREPARATION OF 2-METOXY-5-SULFONIL (SUBSTITUTED) -BENZAMIDES - (- SUBSTITUTED
SE409716B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF 11BETA-ALKYL-DELTAŸ4-ESTRENES
SE7608956L (en) PROCEDURE FOR THE PREPARATION OF 2- (PHENOXIALKYLTIO) -5-NITROIMIDAZOLES
NO143746C (en) PROCEDURE FOR THE PREPARATION OF POLY-N-ISOPROPYL IMINOALANES
SE409994B (en) PROCEDURE FOR THE PREPARATION OF AMIDINOCARBAMIDS
SE411211B (en) PROCEDURE FOR THE PREPARATION OF 3-HALOGENCE PHALOSPORINS
SE7613500L (en) PROCEDURE FOR THE PREPARATION OF CEFEM DERIVATIVES
SE401835B (en) PROCEDURE FOR THE PREPARATION OF 17BETA-HYDROXI-16,16-DIMETHYLEST-4-EN-3-ON

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7407913-8

Effective date: 19940710

Format of ref document f/p: F